Exosome-mediated stable epigenetic repression of HIV-1

Human Immunodeficiency Virus (HIV-1) produces a persistent latent infection. Control of HIV-1 using combination antiretroviral therapy (cART) comes at the cost of life-shortening side effects and development of drug-resistant HIV-1. An ideal and safer therapy should be deliverable in vivo and target...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrivastava, Surya, Ray, Roslyn M., Holguin, Leo, Echavarria, Lilliana, Grepo, Nicole, Scott, Tristan A., Burnett, John, Morris, Kevin V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452652/
https://www.ncbi.nlm.nih.gov/pubmed/34545097
http://dx.doi.org/10.1038/s41467-021-25839-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452652/
https://www.ncbi.nlm.nih.gov/pubmed/34545097
http://dx.doi.org/10.1038/s41467-021-25839-2

Ejemplares similares